Drug Developer Accused Of Botching 401(k) Plan Management
A group of Pharmaceutical Product Development 401(k) plan participants have accused the drug development company of costing workers millions of dollars in retirement savings by saddling the plan with high-cost investment...To view the full article, register now.
Already a subscriber? Click here to view full article